Ascentage Pharma Group International - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
AAPG Nasdaq 8071 www.ascentage.cn

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ascentage Pharma Group International

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress - Jun 14th, 2026 5:30 pm
A Look At Ascentage Pharma Group International’s Valuation After Recent Share Price Weakness - Jun 8th, 2026 6:05 am
Ascentage Pharma (AAPG) Reports Phase 1b Olverembatinib Data - Jun 5th, 2026 3:03 pm
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026 - May 31st, 2026 5:30 pm
Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026 - May 31st, 2026 5:30 pm
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026 - May 31st, 2026 5:30 pm
Global Growth Companies Insiders Favor With Up To 40% Earnings Growth - May 25th, 2026 3:35 am
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026 - May 21st, 2026 6:00 pm
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress - May 12th, 2026 8:15 pm
Ascentage Pharma to Participate in Three Upcoming Investor Conferences - May 12th, 2026 6:00 am
Global Growth Companies With High Insider Ownership In April 2026 - Apr 22nd, 2026 3:35 am
Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026 - Apr 21st, 2026 6:00 pm
Global Growth Companies With High Insider Ownership - Apr 20th, 2026 3:35 am
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting - Apr 19th, 2026 6:00 pm
Global Insights Into 3 Growth Stocks With High Insider Ownership - Apr 17th, 2026 3:36 am
Ascentage Pharma Builds Momentum With 2 'Potential Blockbuster' Drugs, Oppenheimer Says - Mar 27th, 2026 9:26 am
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates - Mar 25th, 2026 5:00 pm
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026 - Mar 17th, 2026 6:00 pm
Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026 - Mar 11th, 2026 6:00 am
A Look At Ascentage Pharma Group International’s Valuation After Recent Share Price Moves - Mar 8th, 2026 11:05 pm